APA

Gerber D. E., Hao G., Watkins L., Stafford J. H., Anderson J., Holbein B., Öz O. K., Mathews D., Thorpe P. E., Hassan G., Kumar A., Brekken R. A. & Sun X. (20151109). Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. : American journal of nuclear medicine and molecular imaging.

Chicago

Gerber David E, Hao Guiyang, Watkins Linda, Stafford Jason H, Anderson Jon, Holbein Blair, Öz Orhan K, Mathews Dana, Thorpe Philip E, Hassan Gedaa, Kumar Amit, Brekken Rolf A and Sun Xiankai. 20151109. Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. : American journal of nuclear medicine and molecular imaging.

Harvard

Gerber D. E., Hao G., Watkins L., Stafford J. H., Anderson J., Holbein B., Öz O. K., Mathews D., Thorpe P. E., Hassan G., Kumar A., Brekken R. A. and Sun X. (20151109). Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. : American journal of nuclear medicine and molecular imaging.

MLA

Gerber David E, Hao Guiyang, Watkins Linda, Stafford Jason H, Anderson Jon, Holbein Blair, Öz Orhan K, Mathews Dana, Thorpe Philip E, Hassan Gedaa, Kumar Amit, Brekken Rolf A and Sun Xiankai. Tumor-specific targeting by Bavituximab, a phosphatidylserine-targeting monoclonal antibody with vascular targeting and immune modulating properties, in lung cancer xenografts. : American journal of nuclear medicine and molecular imaging. 20151109.